Assessment of therapeutic success after interstitial brachytherapy of hepatocellular carcinoma using the LI-RADS-TRA algorithm
Recruiting
- Conditions
- C22.0Liver cell carcinoma
- Registration Number
- DRKS00033714
- Lead Sponsor
- MU München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
• HCC patients =18 years
• Z.n. Primary brachytherapy for HCC at the LMU Clinic with subsequent liver transplant
• Presence of multiphasic MRI up to a maximum of 90 days before brachytherapy
• At least one multiphase MRI scan after brachytherapy up to a maximum of 90 days before transplantation
• No additional treatment of HCC before transplantation
Exclusion Criteria
• Incomplete imaging or insufficient imaging that interferes with correct image interpretation (e.g. due to artifacts).
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation LR-TRA with histopathology.
- Secondary Outcome Measures
Name Time Method Interreader Agreement LR-TRA pre- and post-interventional, diagnostic performance of MRI for predicting histological tumor necrosis